Literature DB >> 8000286

Does hyperbaric oxygen have a cancer-causing or -promoting effect? A review of the pertinent literature.

J J Feldmeier1, R D Heimbach, D A Davolt, M J Brakora, P J Sheffield, A T Porter.   

Abstract

We reviewed all known published reports or studies related to a possible cancer-causing or growth-enhancing effect by hyperbaric oxygen. Published articles were retrieved using Medline searches for the period 1960-1993. Additional references were obtained from bibliographies included in those articles discovered in the computer search. Also, hyperbaric medicine text books and the published proceedings of international hyperbaric conferences were visually searched. Studies and reports discovered in this fashion and related to the topic were included in the review. Twenty-four references were found: 12 were clinical reports, 11 were animal studies, and 1 reported both an animal study and a clinical report. Three clinical reports suggested a positive cancer growth enhancement, whereas 10 clinical reports showed no cancer growth enhancement. Two animal studies suggested a positive cancer-enhancing effect, and 10 animal studies showed no such effect. (The report that included both animals and humans is counted in both groups). The vast majority of published reports show no cancer growth enhancement by HBO exposure. Those studies that do show growth enhancement are refuted by larger subsequent studies, are mixed studies, or are highly anecdotal. A review of published information fails to support a cancer-causing or growth-enhancing effect by HBO.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8000286

Source DB:  PubMed          Journal:  Undersea Hyperb Med        ISSN: 1066-2936            Impact factor:   0.698


  8 in total

1.  Exposure to hyperbaric oxygen induces cell cycle perturbation in prostate cancer cells.

Authors:  J E Kalns; E H Piepmeier
Journal:  In Vitro Cell Dev Biol Anim       Date:  1999-02       Impact factor: 2.416

2.  Hyperbaric oxygen therapy for late radiation tissue injury in gynaecological patients.

Authors:  A Kongsgaard Rud; S Bjørgo; G B Kristensen; U E Kongsgaard
Journal:  Support Care Cancer       Date:  2009-03-25       Impact factor: 3.603

3.  Severity of hematuria effects resolution in patients treated with hyperbaric oxygen therapy for radiation-induced hematuria.

Authors:  Michael A Liss; Kathryn Osann; Jane Cho; Walter C Chua; Atreya Dash
Journal:  Urol Int       Date:  2013-08-06       Impact factor: 2.089

4.  Re-evaluate the effect of hyperbaric oxygen therapy in cancer - a preclinical therapeutic small animal model study.

Authors:  Sneha Pande; Amit Sengupta; Anurag Srivastava; Rajiv P Gude; Arvind Ingle
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

Review 5.  Hyperbaric oxygen therapy and cancer--a review.

Authors:  Ingrid Moen; Linda E B Stuhr
Journal:  Target Oncol       Date:  2012-10-02       Impact factor: 4.493

Review 6.  Radiation induced temporal lobe necrosis in patients with nasopharyngeal carcinoma: a review of new avenues in its management.

Authors:  Jing Chen; Meera Dassarath; Zhongyuan Yin; Hongli Liu; Kunyu Yang; Gang Wu
Journal:  Radiat Oncol       Date:  2011-09-30       Impact factor: 3.481

7.  Synergistic inhibitory effect of hyperbaric oxygen combined with sorafenib on hepatoma cells.

Authors:  Hai-Shan Peng; Ming-Bin Liao; Mei-Yin Zhang; Yin Xie; Li Xu; Yao-Jun Zhang; X F Steven Zheng; Hui-Yun Wang; Yi-Fei Chen
Journal:  PLoS One       Date:  2014-06-23       Impact factor: 3.240

8.  Pelvic radiation disease management by hyperbaric oxygen therapy: prospective study of 44 patients.

Authors:  Mehdi Ouaïssi; Stephanie Tran; Diane Mege; Vivien Latrasse; Alain Barthelemy; Nicolas Pirro; Philippe Grandval; James Lassey; Igor Sielezneff; Bernard Sastre; Mathieu Coulange
Journal:  Gastroenterol Res Pract       Date:  2014-01-27       Impact factor: 2.260

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.